Current insights and emerging trends in early-onset type 2 diabetes.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing existing literature without systematic search methodology or primary data.
PubMed 37708901 · doi:10.1016/S2213-8587(23)00225-5
What was done
The authors synthesized published evidence regarding the epidemiology, pathophysiology, complications, and management challenges of early-onset type 2 diabetes, evaluating distinct age groups including pediatric-onset (younger than 19 years) and young adults (aged 19–39 years).
What was found
The abstract reports no numerical data or risk statistics. Early-onset type 2 diabetes is increasing globally and carries a disproportionate excess risk of microvascular complications, adverse cardiovascular outcomes, premature death, and adverse pregnancy outcomes compared to later-onset disease. Young adults (19–39 years) represent a larger proportion of cases than pediatric cohorts but are undercharacterized and unrepresented in clinical trials supporting current management guidelines.
Why it matters
Standard management strategies derived from older adult populations appear less effective in younger individuals who face distinct psychosocial, occupational, and stigma-related self-management challenges. Highlighting this evidence gap defines the need for age-tailored clinical trials before irreversible multimorbidity occurs.
Limits
This is a narrative review without systematic search protocols or meta-analytic data. The primary literature for young adults aged 19–39 years is noted to be sparse, and the abstract provides no quantitative effect sizes or precise sample counts.
Cited by
- supports Type 2 diabetes has historically not been a pediatric disease and has recently emerged as an international health problem among children.